Histoplasmosis is the most common endemic mycosis in individuals with AIDS, occurring in 2%-5% of this population. Infection is more likely to be disseminated than in immunocompetent individuals and generally presents insidiously with nonspecific symptoms. The gastrointestinal tract is involved in 70%-90% of cases of disseminated histoplasmosis, yet gastrointestinal histoplasmosis per se is infrequently encountered in patients with AIDS. The diagnosis of gastrointestinal histoplasmosis is often not suspected, particularly in areas of nonendemicity, and a delay in diagnosis may lead to increased morbidity and risk of death. Since antifungal therapy improves outcome for 180% of AIDS patients with histoplasmosis, it is essential that caregivers be aware of the varied presentations of gastrointestinal histoplasmosis in order to diagnose and to treat this potentially life-threatening infection effectively.
The dimorphic fungus Histoplasma capsulatum is increasingly recognized as an important pathogen in patients with AIDS. Histoplasmosis, of which the occurrence in patients with AIDS was first described in 1983 [1, 2] , is now the most commonly diagnosed endemic mycosis in this population [3] . Both the risk of developing histoplasmosis and the severity of illness increase as immune function declines in HIV-infected individuals [3] . Disseminated histoplasmosis (DH), which is more likely to be encountered in patients whose CD4 ϩ cell counts are !200 cells/mm 3 [4] , is invariably fatal if not treated [3] . Although involvement of the gastrointestinal (GI) tract is common in DH, GI manifestations are considered to be rare, occurring in only 3%-12% of patients [4, 5] . The more common symptoms such as diarrhea and abdominal pain are nonspecific, and histoplasmosis may not be considered as a possible diagnosis, particularly in areas of nonendemicity, where caregivers may be unfamiliar with this disease. Investigations for more common etiologies of these symptoms may also delay the diagnosis and treatment of histoplasmosis.
We present a case of GI histoplasmosis involving a patient with AIDS and then review the literature, summarizing the salient features of this presentation of DH and emphasizing those points which should raise suspicion of this infection.
CASE REPORT
A 32-year-old HIV-positive man presented at our clinic in October 1997 after moving from Bloomington, Indiana, where he had lived for the previous 8 years. He had not received any antiretroviral therapy and had been well until August 1997, when he developed progressively worsening periumbilical pain, anorexia, nausea, bilious vomiting, and intermittent diarrhea and lost 30 pounds. He had no fever. Abdominal tenderness to deep palpation in the left periumbilical region and left lower quadrant was noted, without a palpable mass, organomegaly, guarding, or rebound tenderness. A CT scan (with contrast) of the abdomen of a 32-year-old man with progressively worsening periumbilical pain, anorexia, nausea, bilious vomiting, intermittent diarrhea, weight loss, and abdominal tenderness but no fever. The scan, obtained at the time of presentation in October 1997, demonstrates the barium-filled, thickened terminal ileum (arrow) and intra-abdominal lymphadenopathy. Mesenteric, portal, and retroperitoneal lymph nodes were enlarged. 
The patient's CD4
ϩ cell count was 7 cells/mm 3 (2% of the total lymphocyte count) and his HIV virus load was 219,109 copies/mL; highly active antiretroviral therapy was initiated. A CT scan of the abdomen revealed concentric thickening of the terminal ileum, consistent with terminal ileitis, and multiple enlarged mesenteric, retroperitoneal, and portal lymph nodes; hepatosplenomegaly was not noted (figure 1).
Two weeks later, the patient developed fever. Blood cultures were performed, including cultures in Isolators (Wampole Laboratories), and he was admitted to the hospital 2 days later, after blood cultures were reported to yield mold, which was subsequently identified as H. capsulatum. Amphotericin B therapy was started. Hepatosplenomegaly was noted on admission. A chest radiograph revealed a mild interstitial pattern and small bilateral pleural effusions.
Colonoscopy revealed a friable, polypoid cecal mass containing areas of necrosis (figure 2). The endoscope could not enter the terminal ileum because of the obstructing lesion. 
REVIEW OF THE LITERATURE
A total of 25 cases of GI histoplasmosis in patients with AIDS and 2 cases in patients with probable AIDS from between 1986 and October 1999 were identified in the English-language medical literature with use of MEDLINE.
Selected demographic and clinical features of each case patient, including our patient, are shown in table 1. Two-thirds of cases (19/28) have occurred in males. All reported cases have occurred in adults; the mean age was 42 years (range, 25-71 years). In 13 cases, a geographic risk factor (native of or residence in an area of endemicity) was identified (table 1) . No particular HIV risk factor was dominant among the 20 patients for whom this information was documented. CD4 ϩ cell counts at the time of diagnosis of histoplasmosis were documented in 14 cases and ranged from 6 cells/mm 3 to 200 cells/mm 3 ; median and mean CD4 ϩ cell counts could not be determined from the data given. Histoplasmosis was the AIDS-defining illness for 8 (31%) of the 26 individuals known to be HIV-infected. Presenting symptoms and physical findings of the 28 patients are summarized in table 2. The duration of symptoms in most patients was consistent with a subacute presentation; two-thirds of patients had symptoms for 11 month before diagnosis (range, 1 day to 24 months; median, 1 month). Abdominal pain and fever were the most common symptoms, occurring in 20 of 28 patients (71%). Weight loss (50% of patients) and diarrhea (50% of patients) were also common, but GI bleeding and obstruction were rare. Perforation occurred as a late complication in 3 cases. Pulmonary symptoms (cough and/or dyspnea) were presenting complaints for only 4 patients (14%), of whom 3 had abnormalities visible on a chest radiograph. Physical findings attributable to GI histoplasmosis were infrequent. A palpable abdominal mass and hepatomegaly and/or splenomegaly were the most common findings, present in only 25% of patients.
Radiological findings were frequently abnormal but nonspecific. Of 17 chest radiographs reported, bilateral or diffuse parenchymal abnormalities were noted on 11 (65%; table 3). Abdominal imaging, including plain radiography, barium studies, and CT scans, were performed for 18 patients. Barium study findings were normal for only 1 of 14 patients [8] , and 9 of 10 CT scans revealed abnormalities (table 3) .
Tissue for pathology and culture was obtained during endoscopy and/or surgery from 26 patients and at autopsy from 2 patients. Lesions of GI histoplasmosis were localized to the large intestine in 17 patients (61%), small intestine in 7 (25%), both large and small intestine in 3 (11%), and the distal esophagus in 1 (3%). Gross pathology was abnormal in all patients and included a mass, with or without ulceration, in 11 patients (39%); ulceration alone in 8 (29%); strictures in 4 (14%), which were ulcerated in 2 and associated with bowel perforation in 1; bowel edema in 2 (7%); and nodules, polyps, or erythema in 1 patient each (3%). In 25 (89%) of the 28 cases, characteristic budding yeasts of H. capsulatum were demonstrated by fungal or silver stain.
The diagnosis was made means of electron microscopy in 1 case [21] ; pathologic examination of GI tissue specimens was negative in 2 cases and the diagnosis was established on the basis of bone marrow pathology [14] or positive culture of bowel and other tissue specimens for H. capsulatum [10] ). Granulomas were observed in 12 of 14 specimens in which they were specifically sought. GI specimens were obtained from 11 patients fungal culture; results were positive for 10. Other specimens cultured on admission, including blood, bronchoalveolar lavage, lymph node, liver, and spleen specimens, yielded positive culture results for only 9 of 17 patients.
Histoplasma serologic testing was documented for 9 of 28 cases; results were positive (IgG titer of у1:8) for only 4 (44%). Results of urine antigen detection were positive (у2 units) for 3 of 4 patients from whom a specimen was obtained. Results of serum antigen detection for the same 4 patients were positive (у1 unit) for only 1 patient (whose urine was also antigenpositive).
Four patients who received no therapy died rapidly (table  1) . Treatment was not documented in 2 cases. Of the remaining 22 patients, 1 received ketoconazole and the other 21 received either an amphotericin B preparation alone or amphotericin B followed by itraconazole. Most appear to have received longterm maintenance therapy, although treatment regimens were Abdominal radiography (n p 5) not described in detail in most instances. Survival of 3-24 months was documented for 17 treated patients, 2 of whom had relapses of histoplasmosis.
DISCUSSION
Histoplasmosis is increasingly recognized as an important infection in patients with AIDS. Disseminated disease occurs in 95% of affected patients with AIDS [4] . The infrequency of the initial presentation of histoplasmosis as a GI disease is surprising, considering that H. capsulatum can be identified in the GI tract in 70%-90% of patients with DH for whom autopsies are performed [6, 24] . Lesions of GI histoplasmosis occur mainly in the large bowel and predominantly in the ileocecal area, presumably because of the abundance of lymphoid tissue in this area [14] . They can be variable in appearance and may be mistaken for Crohn's disease or malignant tumors. Four pathologic patterns of GI histoplasmosis have been described [13] : no gross abnormalities visible but infected macrophages within the lamina propria; pseudopolyps or plaques caused by collections of infected macrophages; ulceration with tissue necrosis; and localized inflammation. GI symptoms such as diarrhea, abdominal pain, bowel obstruction, GI bleeding, and bowel perforation have been reported to occur in 2.8% [4] to 65% [25] of patients with AIDS and DH; however, in the latter study [25] , it is not clear what proportion of GI symptoms were attributable to histoplasmosis alone. In the series by Johnson et al. [26] , diarrhea in 9 of 48 cases was attributed to other pathogens, and neither of 2 patients with GI histoplasmosis had diarrhea. Identification of H. capsulatum from the GI tract should be considered pathologic, but in the presence of other potential bowel pathogens it may be difficult to determine the primary cause of GI symptoms with certainty. Similarly, in our patient, it is not possible to assess the role that cytomegalovirus might have played in his illness.
Symptoms of GI histoplasmosis can mimic other AIDS-associated enteropathies, making the diagnosis difficult. In the cases reviewed, abdominal pain, fever, weight loss, and diarrhea were the most common presenting symptoms (table 2) . GI bleeding and bowel obstruction, which are 2 major complications of GI histoplasmosis, each occurred on presentation in !25% of patients. The third major complication, bowel perforation, occurred in only 3 patients (the present case and [13, 23] ), after histoplasmosis was diagnosed. The absence of fever in almost one-third of patients is notable, as typically 180% of patients with AIDS with DH are febrile [4, 25, 26] . Also in contrast to previous studies of DH [4, 24] , respiratory symptoms were uncommon, reported in only 14% of cases. These large differences may be due to the retrospective nature of the literature review and selective reporting of patients' symptoms.
A palpable abdominal mass and/or hepatosplenomegaly, the 2 most common physical findings in our series, or any of the 3 major complications noted above should prompt investigations for histoplasmosis or other underlying pathology. A history of residence in an area where H. capsulatum is known to be endemic and the presence of GI or abdominal symptoms should also alert the clinician to the possibility of GI histoplasmosis.
Isolation of H. capsulatum has historically provided the strongest evidence of infection, but identification of the organism may take up to 4 weeks [27] . Specimens most likely to yield H. capsulatum are blood and bone marrow (both in up to 91% of cases of DH) [4, 25, 26, 28, 29] . However, it is noteworthy that in the cases we reviewed, blood or bone marrow culture results were much less likely to be positive (40%-55%). Possible explanations for this discrepancy include the small number of patients for whom these investigations were performed and an inadequate incubation period for conventional blood cultures. Conventional blood culture systems are sensitive for detecting fungemia but can take up to 8 weeks to produce positive results [25] . Lysis-centrifugation (Isolator) cultures are more sensitive for fungal pathogens and can detect growth earlier [30] but are more expensive and more laborintensive than conventional systems. Sensitivities might have been improved if fungal cultures had been performed for all patients, particularly if lysis-centrifugation cultures were employed.
Glycoprotein antigen detection in blood or urine specimens appears to be useful in diagnosing GI histoplasmosis, although definite conclusions cannot be made on the basis of the cases we reviewed, since these tests were not often performed. The low sensitivity of urine antigen detection in our series (75%) is largely due to the very small number of cases in which the test was performed. More than 95% of patients with DH have at least 1 positive test of blood, urine, or CSF, with urine testing having the highest sensitivity (190%) [4] . False-positive reactions do occur with certain other mycoses (including those due to Coccidioides immitis, Paracoccidioides brasiliensis, Blastomyces dermatitidis, and Penicillium marneffei) or because of rheumatoid factor-like activity [31] [32] [33] . Antigen detection can also be used to monitor response to therapy and predict relapses: levels decline with effective therapy [4, 34] , and increases of у2 units in blood or urine are associated with relapse or recurrence [4] . The high sensitivity of antigen detection tests in DH and the ease of specimen procurement may make this the diagnostic method of choice for GI histoplasmosis, although more conclusive data are required. Antigen detection assays are presently performed at only 1 laboratory in North America (Histoplasmosis Reference Laboratory, Indianapolis).
Histoplasmin skin testing is unhelpful for diagnosing DH, especially in areas of endemicity, where the prevalence of positive skin tests is high [31] . Serological tests are of limited diagnostic value and cannot reliably predict the development of DH [27] . Serological cross-reactivity also occurs in other fungal infections such as blastomycosis, aspergillosis, coccidioidomycosis, and candidiasis [35] . Furthermore, although antibodies generally develop within 6 weeks of exposure [31] , the immune response may be blunted in immunocompromised individuals [36] . Thus, positive results of serologic tests may indicate only prior exposure, and can be falsely negative in cases of acute infection.
Pathological examination and fungal culture of GI tissue specimens are sensitive methods for diagnosing GI histoplasmosis. In this series, 10 (91%) of 11 biopsy specimens yielded H. capsulatum, and in 25 (89%) of 28 cases, characteristic budding yeasts were noted on histologic examination with use of fungal or silver stains. Granulomas-a nonspecific finding that may suggest other diagnoses, in addition to histoplasmosis-were not uncommon. Results of fungal culture or histologic examination (or both) were positive for 27 (96%) of 28 patients. Although an invasive procedure is required to obtain tissue specimens, pathological examination of GI specimens can provide a rapid and accurate diagnosis of GI histoplasmosis. The importance of obtaining tissue in these cases, especially when other investigations fail to establish a diagnosis, should be emphasized.
Systemic antifungal therapy appears to be the mainstay of therapy in GI histoplasmosis, as it is in DH. Mortality associated with DH is high, and death can be rapid if treatment is withheld. Of the cases we reviewed, 17 of 22 treated patients for whom outcome was recorded survived for 3-24 months in follow-up, although details regarding therapy were incomplete; thus, treatment and survival analyses are not possible. Currently, induction therapy with amphotericin B is recommended for severe disease and is superior to itraconazole in this setting [37] . Overall, 180% of patients respond to amphotericin B [4, 31] . Itraconazole can be used to treat mild cases of DH [37] and is effective in preventing relapses [38] . The relative ease of administration and lack of adverse effects make itraconazole preferable to amphotericin B for maintenance therapy, although attention must be paid to potential drug interactions.
Treatment with fluconazole, which is less effective than itraconazole in preventing relapses, may be considered for individuals who require rifampin or in whom absorption of itraconazole is demonstrated to be poor, but failures have been reported [39] . Although voriconazole is reported to be effective against H. capsulatum in vitro [40] , its role in the treatment of histoplasmosis has not been established. Relapses can occur despite maintenance therapy and regardless of the antifungal agent used, usually within 18 months of induction therapy [4] . However, with recent successes in discontinuing maintenance therapy for other opportunistic infections for patients with AIDS who have responded to highly active antiretroviral therapy, the need for chronic antifungal therapy in patients with histoplasmosis who respond to antiretroviral treatment should be examined more closely.
Surgical intervention would seem to be indicated in cases of bowel perforation and refractory bowel obstruction due to GI histoplasmosis, but no general recommendations can be made regarding the role of surgery on the basis of the cases reviewed here. Histoplasmosis was diagnosed based on analysis of surgically obtained tissue specimens in 7 cases, although endoscopically obtained specimens might also have been diagnostic. It is unclear whether surgical resection in addition to systemic antifungal therapy might lead to an improved outcome in some cases.
CONCLUSION
GI histoplasmosis in patients with AIDS is an infrequently encountered, treatable infection. The presence of major complications of GI histoplasmosis (obstruction, GI bleeding, and perforation), an abdominal mass, hepatosplenomegaly, or GI symptoms in conjunction with fever or weight loss should alert the caregiver to the possibility of GI histoplasmosis. While the index of suspicion should be particularly high in areas of endemicity and for patients known to have resided in such an area, a negative exposure history should not be relied upon to exclude the diagnosis.
Findings of radiological and endoscopic investigations are almost always abnormal in cases of GI histoplasmosis. Sensitivity of blood and bone marrow cultures in GI histoplasmosis can be optimized with use of lysis-centrifugation methods. Histologic examination of affected tissue can provide a quick, sensitive, accurate diagnosis of GI histoplasmosis, and attempts should be made to obtain tissue specimens if possible. Although data are lacking specifically for GI histoplasmosis, antigen detection in urine (or blood) is a highly sensitive and rapid diagnostic method in DH. The ease of specimen collection makes this an extremely valuable test, which may allow earlier diagnosis of GI histoplasmosis and potentially lead to improved outcomes for these patients.
